Global Newborn Screening Market Segmentation, By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents, Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics) – Industry Trends and Forecast to 2031
Newborn Screening Market Analysis
Over the years, there has been massive increment in the cases of congenital diseases in newborns. According to the Indian Pediatric Academy, Congenital cardiac disease affects 9 out of every 1,000 children. The congenital cardiac disease affects around 200,000 children every year. The increasing rate of these congenital diseases have largely inclined the population (especially parents) towards the newborn screening. The market is estimated to show expand at a high rate over the forecasted period.
Newborn Screening Market Size
Global newborn screening market size was valued at USD 1.07 billion in 2023 and is projected to reach USD 2.09 billion by 2031, with a CAGR of 8.80% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Newborn Screening Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Key Market Players
|
PerkinElmer Inc., (U.S), Demant A/S (Denmark), Natus Medical Incorporated (U.S), Bio-Rad Laboratories (U.S), Luminex Corporation (US), F. Hoffmann-La Roche Ltd., (Switzerland), Thermo Fisher Scientific Inc., (U.S), Bruker (US), Danaher (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies Inc., (U.S), and RECIPE Chemicals + Instruments GmbH (Germany)
|
Newborn Screening Market Definition
The new-born screening test is used to detect hazardous or fatal disorders to infants and can have a detrimental impact on their long-term health. About thirty metabolic and genetic illnesses, such as galactosemia (GAL), phenylketonuria (PKU), sickle cell anemia, and congenital hypothyroidism, can be detected by the newborn screening test (CH). Newborn screening exams include blood tests, pulse oximetry, and hearing tests, among other procedures. These screening tests allow healthcare providers to detect and treat problems that contribute to a baby's healthy growth and development.
Newborn Screening Market Dynamics
Drivers
- Growing Burden Of Disorders and Conditions that Require New-born Screening
The growing neonatal population base along with the rising cases of congenital diseases in newborns is the most significant factor driving the growth for this market. Moreover, various conditions requiring screening are also expected to accelerate the market's overall growth.
Furthermore, the increasing awareness and rising demand for newborn diagnoses are also expected to fuel market growth. Moreover, the benefits of newborn screening as it can detect various disorders such as phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell disease, tyrosinemia, among others, also cushions the market's growth within the forecasted period. The numerous benefits of the newborn screening test are also projected to bolster the growth of the market.
Opportunities
- Favourable Programs and Advancements To Generate Opportunities
Moreover, favorable government programs and legislations and technological advancements are estimated to generate lucrative opportunities for the market. The launch of improved performance instruments of mass spectroscopy and oximeters will further offer numerous growth opportunities for the market.
Restraints/Challenges Global Newborn Screening Market
- Limitations Within Market Will Hamper the Growth
On the other hand, lack of trained professionals along with the lack of technologically advanced instruments for testing is expected to obstruct market growth.
- Availability Of Refurbished Products
Also, the availability of refurbished products further minimizes demand for the newer newborn screening products, which is projected to challenge the newborn screening market in the forecast period of 2022-2029.
This newborn screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the newborn screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Newborn Screening Market
The healthcare sector largely industry impacted by the outbreak of COVID-19. Imposition of the lockdown and social distancing restrictions by the government in travel, public gatherings, business operations, and shelter-in-place orders to curb the COVID-19 pandemic outbreak, led to limited or non-availability of medical facilities/treatment centers and also halt in various operations, reduced demand and supply chain disruptions, limiting the healthcare sector's expansion.
COVID-19 has had a minimal impact on the newborn screening business, and the market was still growing steadily. The market growth was still substantially rising because of newborns' illness cases. Legislation in key markets has already stressed the importance of newborn screening, with strict measures in place to monitor newborn health and protect babies from disorders like COVID-19. Many screening laboratories and government organizations educate parents about their children's health. A huge increase in diseases necessitated a large number of screening systems, propelling the fledgling screening business forward.
Newborn Screening Market Scope
The newborn screening market is segmented on the basis of test type, product type, technology, disease type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Dried Blood Spot Test
- Hearing Screen Test
- Critical Congenital Heart Diseases (CCHD) Test
Product Type
- Instruments
- Reagents
- Assay Kits
Technology
- Tandem Mass Spectrometry
- Hearing Screen Technology
- Pulse Oximetry Screening Technology
- Immunoassays and Enzymatic Assays
- Electrophoresis
- DNA-Based Assays
Disease Type
- Critical Congenital Heart Diseases
- Newborn Hearing Loss
- Sickle Cell Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Maple Syrup Urine Disease
- Others
End User
- Hospital
- Paediatric Clinics
- Clinics
Newborn Screening Market Regional Analysis
The newborn screening market is analyzed and market size insights and trends are provided by country, test type, product type, technology, disease type and end user as referenced above.
The countries covered in the newborn screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the newborn screening market because of the presence of major players, availability of newborn screening programs and favorable reimbursement policies within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increasing screening rate and surge in the awareness about early diagnosis within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The newborn screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for newborn screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the newborn screening market. The data is available for historic period 2010-2020.
Newborn Screening Market Share
The newborn screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to newborn screening market.
Newborn Screening Market Leaders Operating in the Market Are:
- PerkinElmer Inc., (U.S)
- Demant A/S (Denmark)
- Natus Medical Incorporated (U.S)
- Bio-Rad Laboratories (U.S)
- Luminex Corporation (US)
- F. Hoffmann-La Roche Ltd., (Switzerland)
- Thermo Fisher Scientific Inc., (U.S)
- Bruker (US)
- Danaher (US)
- Medtronic (Ireland)
- Chromsystems Instruments & Chemicals GmbH (Germany)
- Trivitron Healthcare (India)
- Baebies Inc., (U.S)
- RECIPE Chemicals + Instruments GmbH (Germany)
Latest Developments in Newborn Screening Market
- In September 2020, PerkinElmer, Inc., a worldwide company devoted to developing for a healthy society, has gained CE-IVD certification for their EONISTM newborn screening assay, which screens for SMA (spinal muscular atrophy), SCID (severe combined immunodeficiency), and XLA (X-linked agammaglobulinemia). This IVD RT-PCR assay is designed to interact with PerkinElmer's full newborn screening workflow, giving labs a complete, single-source solution that includes everything from sample to solution
SKU-